This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Leukaemia
  • /
  • Rituximab plus bendamustine or chlorambucil for ch...

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study.

Read time: 1 mins
Published:1st Feb 2018
Author: Michallet AS, Aktan M, Hiddemann W, Ilhan O, Johansson P, Laribi K et al.
Source: Haematologica
Availability: Pay for access, or by subscription
Ref.:Haematologica. 2018. pii: haematol.2017.170480.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest